NO20004835L - Fuktighetsaktiverbart terapeutisk system - Google Patents

Fuktighetsaktiverbart terapeutisk system

Info

Publication number
NO20004835L
NO20004835L NO20004835A NO20004835A NO20004835L NO 20004835 L NO20004835 L NO 20004835L NO 20004835 A NO20004835 A NO 20004835A NO 20004835 A NO20004835 A NO 20004835A NO 20004835 L NO20004835 L NO 20004835L
Authority
NO
Norway
Prior art keywords
skin
mucous membrane
active agent
activating agent
therapeutic system
Prior art date
Application number
NO20004835A
Other languages
English (en)
Norwegian (no)
Other versions
NO20004835D0 (no
Inventor
Stefan Bracht
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO20004835L publication Critical patent/NO20004835L/no
Publication of NO20004835D0 publication Critical patent/NO20004835D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20004835A 1998-03-30 2000-09-26 Fuktighetsaktiverbart terapeutisk system NO20004835D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19814087A DE19814087A1 (de) 1998-03-30 1998-03-30 Feuchtigkeitsaktivierbares therapeutisches System
PCT/EP1999/001802 WO1999049853A1 (fr) 1998-03-30 1999-03-18 Systeme therapeutique pouvant etre active par l'humidite

Publications (2)

Publication Number Publication Date
NO20004835L true NO20004835L (no) 2000-09-26
NO20004835D0 NO20004835D0 (no) 2000-09-26

Family

ID=7862905

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004835A NO20004835D0 (no) 1998-03-30 2000-09-26 Fuktighetsaktiverbart terapeutisk system

Country Status (13)

Country Link
US (1) US7175853B1 (fr)
EP (1) EP1069892B1 (fr)
JP (1) JP4252212B2 (fr)
KR (1) KR100550886B1 (fr)
AT (1) ATE221774T1 (fr)
AU (1) AU3331299A (fr)
CA (1) CA2326662C (fr)
DE (2) DE19814087A1 (fr)
DK (1) DK1069892T3 (fr)
ES (1) ES2182507T3 (fr)
NO (1) NO20004835D0 (fr)
PT (1) PT1069892E (fr)
WO (1) WO1999049853A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10053397A1 (de) 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10137162A1 (de) * 2001-07-30 2003-02-20 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
DE10159745A1 (de) 2001-12-05 2003-07-03 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort
DE102007041734A1 (de) * 2006-12-20 2008-06-26 Tesa Ag Repulpierbare Klebmassen
EP2255802B1 (fr) * 2008-02-27 2018-01-17 Hisamitsu Pharmaceutical Co., Inc. Timbre transdermique adhésif et produit conditionné
JP5537412B2 (ja) 2008-02-27 2014-07-02 久光製薬株式会社 貼付製剤
DE102008013701A1 (de) * 2008-03-11 2009-09-17 Lts Lohmann Therapie-Systeme Ag Transdermales Therapeutisches System mit stabilisierter Membran
WO2010123103A1 (fr) * 2009-04-24 2010-10-28 久光製薬株式会社 Sac de conditionnement contenant un timbre adhésif et procédé de stockage du timbre adhésif
JP5514815B2 (ja) * 2009-05-21 2014-06-04 久光製薬株式会社 経皮吸収製剤
DE102009022915A1 (de) * 2009-05-27 2010-12-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit gesteuertem Wirkstofffluss
EP2500038A4 (fr) * 2009-11-12 2015-03-11 Univ Nihon Composition phatmaceutique pour usage externe/
US10076502B2 (en) 2009-12-22 2018-09-18 Luye Pharma Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
US8962014B2 (en) * 2009-12-22 2015-02-24 Acino Ag Transdermal therapeutic system for administering rivastigmine or derivatives thereof
EP2523731B1 (fr) * 2010-01-14 2018-10-24 Novartis AG Utilisation d'un agent modificateur d'hormone adrenale
MY153762A (en) 2010-04-30 2015-03-13 Teikoku Pharma Usa Inc Propynylaminoindan transdermal compositions
DE102010024105A1 (de) * 2010-06-17 2011-12-22 Grünenthal GmbH Transdermale Verabreichung von Memantin
KR101853082B1 (ko) 2011-03-24 2018-04-27 테이코쿠 팔마 유에스에이, 인코포레이티드 활성제층 및 활성제 변환층을 포함하는 경피 조성물
US9918945B2 (en) * 2011-05-31 2018-03-20 Hisamitsu Pharmaceutical Co., Inc. Ropinirole-containing patch and package thereof
JP5913614B2 (ja) 2011-11-09 2016-04-27 テイコク ファーマ ユーエスエー インコーポレーテッド 皮膚新生物の処置方法
US9481777B2 (en) 2012-03-30 2016-11-01 The Procter & Gamble Company Method of dewatering in a continuous high internal phase emulsion foam forming process
KR20150059177A (ko) 2012-11-02 2015-05-29 테이코쿠 팔마 유에스에이, 인코포레이티드 프로피닐아미노인단 경피 조성물
WO2015137872A1 (fr) * 2014-03-13 2015-09-17 Innovator Skåne Ab Système d'administration de médicament en forme de feuille ou tubulaire
KR20190122205A (ko) * 2016-12-29 2019-10-29 퓨어 래티오스 홀딩스, 인크. 모듈식 경피 전달 시스템, 및 관련 제조 및 사용 방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0249343B1 (fr) * 1986-06-13 1992-01-08 Alza Corporation Activation par l'humidité d'un système à libération transdermale des drogues
US4781924A (en) * 1987-11-09 1988-11-01 Alza Corporation Transdermal drug delivery device
US4837027A (en) * 1987-11-09 1989-06-06 Alza Corporation Transdermal drug delivery device
AT392587B (de) * 1988-03-03 1991-04-25 Sandoz Ag Pharmazeutische zusammensetzung enthaltend phenylcarbamate
DE3905051A1 (de) 1989-02-18 1990-08-30 Lohmann Therapie Syst Lts Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (i)
DE3905050A1 (de) * 1989-02-18 1990-08-30 Lohmann Therapie Syst Lts Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (ii)
DE3910543A1 (de) * 1989-04-01 1990-10-11 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung
JPH04124128A (ja) * 1990-09-13 1992-04-24 Lion Corp 肛門部疾患治療用貼付剤
US5989586A (en) 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
GB2290964A (en) * 1994-07-08 1996-01-17 Arto Olavi Urtti Transdermal drug delivery system
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof

Also Published As

Publication number Publication date
PT1069892E (pt) 2002-12-31
ATE221774T1 (de) 2002-08-15
AU3331299A (en) 1999-10-18
DK1069892T3 (da) 2002-12-02
WO1999049853A1 (fr) 1999-10-07
EP1069892B1 (fr) 2002-08-07
ES2182507T3 (es) 2003-03-01
EP1069892A1 (fr) 2001-01-24
KR20010042173A (ko) 2001-05-25
CA2326662C (fr) 2007-01-16
DE19814087A1 (de) 1999-10-14
DE59902270D1 (de) 2002-09-12
JP4252212B2 (ja) 2009-04-08
CA2326662A1 (fr) 1999-10-07
KR100550886B1 (ko) 2006-02-10
NO20004835D0 (no) 2000-09-26
US7175853B1 (en) 2007-02-13
JP2002509879A (ja) 2002-04-02

Similar Documents

Publication Publication Date Title
DK1069892T3 (da) Fugtighedsaktiverbart terapeutisk system
IS4083A (is) Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja
WO2002085447A8 (fr) Reseau de micro-projections avec revetement contenant un principe benefique
TR200003158T2 (tr) Jelleşebilen farmasötik bileşimler
ATE211907T1 (de) Osmotisches arzneimittelfreisetzungssystem
PT974350E (pt) Preparacao contendo tranilast para aplicacao externa e metedo para a sua producao
BR0114909A (pt) Dispositivos de distribuição de drogas transdérmicas possuindo microprotuberâncias revestidas
TW201412342A (zh) 應用微囊化亞硝酸鹽和酸化水凝膠的延時產生一氧化氮的系統和方法
US4039664A (en) Topical griseofulvin composition and method
BR0210994A (pt) Compostos farmacêuticos e de diagnósticos contendo nanopartìculas úteis para tratamento de tecidos e células
BR0009771A (pt) Utilização de derivados de bisindóis indigóides capazes de penetrarem na membrana de células
BR0013283A (pt) Agente farmacêutico que compreende um derivado de benzamida como ingrediente ativo
PORZIO et al. EFFICACY OF A NEW TOPICAL GEL-SPRAY FORMULATION OF KETOPROFEN LYSINE SALT IN THE RAT: PERCUTANEOUS PERMEATIONIN VITROANDIN VIVOAND PHARMACOLOGICAL ACTIVITY
HUP9902032A2 (hu) Peszticid készítmény
BR9912533A (pt) Composição farmacêutica tendo sabor melhorado
US4476115A (en) Analgesic composition and method of treating subdermal pain
DK1019037T3 (da) Lægemiddel indeholdende delta-aminolevulinsyre
JPH11302145A (ja) 日やけ止め化粧料
BR0015422A (pt) Formulações de droga de liberação prolongada
EP1297838A4 (fr) Preparations de gouttes nasales contenant de la pralmoreline
RU2181584C1 (ru) Стимулятор роста волос
IT1158029B (it) Preparato per ridurre traumi dei tessuti in esseri umani o animali e procedeminto per la sua produzione
UA82472C2 (uk) Трансдермальна фармацевтична композиція, що містить ацетилсаліцилову кислоту, для лікування кальцифікації
RU2002126632A (ru) Водная лекарственная композиция для лечения заболеваний кожи
RU94022543A (ru) Основа лекарственного средства и способ ее изготовления

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application